Publication | Open Access

Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma

Tumor BiologySarcomatoid CholangiocarcinomaGastrointestinal OncologyMedicineMtorc2 AssemblyPathologyPeritoneal DisseminationCancer BiologyRadiation OncologyCancer Research